alirocumab vs inclisiran
Side-by-side comparison of alirocumab and inclisiran Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Praluent
Leqvio
Praluent is a medicine that can lower cholesterol. It can also lower the risk of heart problems like heart attack or stroke in some adults.
Leqvio is a medicine that helps lower bad cholesterol (LDL-C) in adults. It is used along with diet and exercise.
Praluent is used to lower LDL cholesterol (bad cholesterol). It is used along with diet and exercise in adults with high cholesterol. It is also used in adults and children 8 years and older who have a genetic condition that causes high cholesterol.
Leqvio is used to lower LDL-C (bad cholesterol) in adults who have high cholesterol. This includes people with a genetic condition called heterozygous familial hypercholesterolemia (HeFH). You should use Leqvio along with a healthy diet and exercise plan.
Praluent is a PCSK9 inhibitor. It works by blocking a protein in your body called PCSK9. Blocking this protein helps your body remove LDL cholesterol from your blood.
Leqvio contains inclisiran, which is a small interfering RNA (siRNA). It targets a substance in the liver called PCSK9. By targeting PCSK9, Leqvio helps your body remove more LDL-C from your blood.
- • Injection site reactions (redness, itching, swelling, pain)
- • Flu
- • Muscle pain
- • Diarrhea
- • Injection site reaction (pain, redness, or rash)
- • Joint pain
- • Bronchitis
- Muscle pain 1,655
- Missed dose 1,364
- Pain at injection site 1,278
- Muscle spasms 1,162
- Joint pain 1,053
- Joint pain 740
- Muscle pain 584
- Pain at the injection site 509
- Increased LDL cholesterol 447
- Pain in an arm or leg 442
Serious allergic reactions have happened with Praluent, sometimes requiring hospitalization. If you have signs of a serious allergic reaction, stop using Praluent and get medical help right away.
You should not take Leqvio if you have had a serious allergic reaction to inclisiran or any of its ingredients. Serious allergic reactions can include swelling of the face, lips, tongue, or throat (angioedema).
There is not enough information about Praluent use during pregnancy to know if it is safe. If you are pregnant or plan to become pregnant, talk to your doctor before using Praluent.
Stop taking Leqvio when you know you are pregnant. Lowering cholesterol may not be helpful during pregnancy and Leqvio could potentially harm the baby.
Also Compare — Nearby Drugs
Compare alirocumab with
How to Read This alirocumab vs inclisiran Comparison
alirocumab is classified in the PCSK9 Inhibitor drug class, while inclisiran sits within the PCSK9 siRNA class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alirocumab has 6,512 submissions while inclisiran has 2,722. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alirocumab and inclisiran — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.